NPS RADAR December 2009

Title Why read this
Prasugrel (Effient) for acute coronary syndromes in people undergoing percutaneous coronary intervention Prasugrel is an alternative to clopidogrel for acute coronary syndrome managed by percutaneous coronary intervention in combination with aspirin.
Immediate-release pramipexole (Sifrol) and extended-release pramipexole (Sifrol ER) for Parkinson’s disease Information on use of immediate-release pramipexole (Sifrol) and extended-release pramipexole (Sifrol ER) for Parkinson's disease.
Olanzapine long-acting injection (Zyprexa Relprevv) for schizophrenia Information about use of olanzapine depot injection (Zyprexa Relprevv) for schizophrenia
Brief item: Varenicline (Champix) safety update: serious neuropsychiatric and dermatological adverse events Safety update regarding serious neuropsychiatric and dermatological adverse events associated with varenicline (Champix)
Brief item: Etoricoxib (Arcoxia): be aware of hypertension risk Information about hypertension risk associated with use of the COX-2 selective NSAID etoricoxib (Arcoxia)
Brief item: New pneumococcal polysaccharide conjugate vaccine (Synflorix) added to the national immunisation schedule Information about use of the 10-valent pneumococcal polysaccharide conjugate vaccine, Synflorix, for Streptococcus pneumoniae
Brief item: Montelukast (Singulair) PBS listed for exercise-induced asthma in children aged 6-14 years Information about use of montelukast (Singulair) for exercise-induced asthma in children aged 6–14 years
Brief item: Authority listing for ciprofloxacin ear drops extended Extension of authority listing for ciprofloxacin ear drops (Ciloxan), 1 November 2009
NPS RADAR December 2009 NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.